866-997-4948(US-Canada Toll Free)

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2018

Published By :

GlobalData

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 2061 Pages

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, Rheumatoid Arthritis Global Clinical Trials Review, H2, 2018" provides an overview of Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Rheumatoid Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 27
In Progress Trials by Phase 28
Clinical Trials by Trial Status 29
Clinical Trials by End Point Status 31
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Rheumatoid Arthritis Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Rheumatoid Arthritis 39
Jul 20, 2018: Koutif Therapeutics Confirms Clinical Candidate Drug 39
Jun 28, 2018: Mallinckrodt Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar Gel (Repository Corticotropin Injection) Achieves its Enrollment Target 39
Jun 27, 2018: Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab 39
Jun 18, 2018: Mallinckrodt Reports Interim Findings Of H.P. Acthar Gel (Repository Corticotropin Injection) Studies 40
Jun 16, 2018: Mallinckrodt Presents Preliminary Interim Findings of Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar Gel (Repository Corticotropin Injection) 40
Jun 13, 2018: Samsung Bioepis and Biogen Announce Pooled Analysis Results of Anti-TNF Biosimilars BENEPALI (etanercept), FLIXABI (infliximab), and IMRALDI (adalimumab) at EULAR 2018 41
Jun 12, 2018: Celltrion Healthcare Showcases Promising Preliminary Results for New Subcutaneous Formulation of CT-P13 (biosimilar infliximab) in Patients with Rheumatoid Arthritis 42
Jun 12, 2018: AbbVie Presents Additional Outcomes Data from Three Upadacitinib Phase 3 Studies in Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR 2018) 42
Jun 11, 2018: Lilly to Unveil New Data on OLUMIANT at the EULAR 2018, Furthering Commitment to Scientific Discovery in Immunology 43
Jun 11, 2018: Lilly to Unveil New Data on Taltz at the EULAR 2018, Furthering Commitment to Scientific Discovery in Immunology 44
Jun 05, 2018: Upadacitinib Monotherapy Meets All Primary and Ranked Secondary Endpoints Versus Methotrexate in a Phase 3 Study in Rheumatoid Arthritis 44
May 29, 2018: MetrioPharm Announces Data Presentation on the Mechanism of Action of MP1032 at the 19th SFRRI Meeting in Lisbon 45
Clinical Trial Profile Snapshots 47
Appendix 2059
Abbreviations 2059
Definitions 2059
Research Methodology 2060
Secondary Research 2060
About GlobalData 2061
Contact Us 2061
Disclaimer 2061
Source 2061

List of Tables
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region, 2018* 8
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 10
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11
Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 12
Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 13
Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2018* 14
Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 15
Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 16
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2018* 18
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 21
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2018* 23
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 24
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 26
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase, 2018* 27
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 28
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 30
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 31
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 32
Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 33
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 35
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 37
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 38

List of Figures
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11
Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 12
Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 13
Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 14
Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 15
Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 16
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2018* 17
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2018* 22
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 24
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 27
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 28
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 29
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 31
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 32
Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 33
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 34
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 36
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 38
GlobalData Methodology 2060

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *